Jeffrey Stein
2016
In 2016, Jeffrey Stein earned a total compensation of $1.7M as President and Chief Executive Officer at Cidara Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,000 |
|---|---|
| Option Awards | $1,080,182 |
| Salary | $430,000 |
| Total | $1,725,182 |
Stein received $1.1M in option awards, accounting for 63% of the total pay in 2016.
Stein also received $215K in non-equity incentive plan and $430K in salary.
Rankings
In 2016, Jeffrey Stein's compensation ranked 5,579th out of 14,075 executives tracked by ExecPay. In other words, Stein earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,579 out of 14,075 | 60th |
Division Manufacturing | 2,012 out of 5,489 | 63rd |
Major group Chemicals And Allied Products | 639 out of 1,895 | 66th |
Industry group Drugs | 480 out of 1,538 | 69th |
Industry Biological Products, Except Diagnostic Substances | 85 out of 279 | 70th |
Source: SEC filing on April 28, 2017.
Stein's colleagues
We found three more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2016.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019